|
Fund Size
(2.71% of Investment in Category)
|
Expense Ratio
(0.63% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 20-Oct-25 | 10055.00 | 0.55% | - | 0.50% | 17/32 |
| 1 Month | 26-Sep-25 | 10536.10 | 5.36% | - | 4.37% | 3/33 |
| 3 Month | 25-Jul-25 | 10201.40 | 2.01% | - | 3.38% | 27/33 |
| 6 Month | 25-Apr-25 | 11125.30 | 11.25% | - | 11.73% | 20/31 |
| YTD | 01-Jan-25 | 10444.80 | 4.45% | - | 4.43% | 14/30 |
| 1 Year | 25-Oct-24 | 10726.40 | 7.26% | 7.22% | 7.46% | 15/28 |
| 2 Year | 27-Oct-23 | 15090.70 | 50.91% | 22.81% | 22.53% | 12/24 |
| 3 Year | 27-Oct-22 | 17950.00 | 79.50% | 21.51% | 20.51% | 5/15 |
| 5 Year | 27-Oct-20 | 33311.90 | 233.12% | 27.19% | 24.82% | 2/9 |
| Since Inception | 11-May-17 | 42182.90 | 321.83% | 18.53% | 16.88% | 15/33 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 25-Oct-24 | 12000 | 13021.95 | 8.52 % | 16.1 % |
| 2 Year | 27-Oct-23 | 24000 | 27396.14 | 14.15 % | 13.28 % |
| 3 Year | 27-Oct-22 | 36000 | 48256.6 | 34.05 % | 19.96 % |
| 5 Year | 27-Oct-20 | 60000 | 101435.97 | 69.06 % | 21.12 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1931.2 | 3.38% | 0.18% | 3.48% (Jul 2025) | 0% (Oct 2024) | 9.89 L | 54.00 k |
| ICICI Bank Ltd. | Private sector bank | 1891.2 | 3.31% | -0.18% | 3.63% (Jul 2025) | 0% (Oct 2024) | 14.03 L | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 1735.3 | 3.03% | -0.30% | 3.66% (Feb 2025) | 2.46% (Oct 2024) | 3.05 L | 0.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 1686.8 | 2.95% | -0.10% | 3.42% (Jul 2025) | 0% (Oct 2024) | 20.04 L | 0.00 |
| Indus Towers Ltd. | Telecom - infrastructure | 1539.6 | 2.69% | -0.01% | 3.6% (Apr 2025) | 0% (Oct 2024) | 44.90 L | 0.00 |
| Ultratech Cement Ltd. | Cement & cement products | 1527.8 | 2.67% | -0.14% | 2.81% (Aug 2025) | 0% (Oct 2024) | 1.25 L | 0.00 |
| Polycab India Limited | Cables - electricals | 1406.2 | 2.46% | 1.11% | 2.46% (Sep 2025) | 0% (Oct 2024) | 1.93 L | 86.00 k |
| Reliance Industries Ltd. | Refineries & marketing | 1398.1 | 2.44% | -0.03% | 4.43% (Jan 2025) | 2.44% (Sep 2025) | 10.25 L | 0.00 |
| Kaynes Technology India Private Ltd. | Industrial products | 1389.2 | 2.43% | 0.67% | 2.43% (Sep 2025) | 1.36% (Oct 2024) | 1.97 L | 35.00 k |
| # Axis Bank Ltd. | Private sector bank | 1188.2 | 2.08% | 2.08% | 2.28% (Apr 2025) | 0% (Oct 2024) | 10.50 L | 10.50 L |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 2.40% |
| MF Units | MF Units | 1.14% |
| Net Receivables | Net Receivables | 0.31% |
Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Motilal Oswal Multi Cap Fund - Direct Plan - Growth | NA | 4310.07 | 4.96 | 4.06 | 13.36 | 17.17 | 0.00 |
| WhiteOak Capital Multi Cap Fund - Direct Plan - Growth | NA | 2405.40 | 5.03 | 4.61 | 14.78 | 12.90 | 0.00 |
| Mirae Asset Multicap Fund - Direct Plan - Growth | NA | 4126.15 | 4.89 | 4.66 | 14.67 | 11.37 | 0.00 |
| Kotak Multicap Fund - Direct Plan - Growth | 4 | 20284.98 | 5.24 | 7.58 | 15.03 | 10.38 | 25.29 |
| Franklin India Multi Cap Fund - Direct Plan - Growth | NA | 4968.91 | 4.98 | 5.47 | 13.10 | 9.81 | 0.00 |
| LIC MF Multi Cap Fund - Direct Plan - Growth | NA | 1715.77 | 5.09 | 3.85 | 13.90 | 9.63 | 0.00 |
| PGIM India Multi Cap Fund - Direct Plan - Growth | NA | 417.39 | 4.52 | 5.15 | 13.89 | 9.30 | 0.00 |
| Bank of India Multicap Fund - Direct Plan - Growth | NA | 909.49 | 5.39 | 4.69 | 12.72 | 9.29 | 0.00 |
| SBI Multicap Fund - Direct Plan - Growth | 3 | 22988.00 | 3.83 | 0.69 | 7.69 | 9.21 | 17.93 |
| Edelweiss Recently Listed IPO Fund - Direct Plan - Growth | NA | 953.90 | 1.88 | 4.18 | 16.26 | 8.80 | 17.37 |
Out of 25 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 2 is/are ranked 4 * , 6 is/are ranked 3 * , 1 is/are ranked 2 * , 3 is/are ranked 1 * , and 12 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Mahindra Manulife Multi Cap Fund - Direct Plan - Growth | 3 | 5719.59 | 5.36 | 2.01 | 11.25 | 7.22 | 21.51 |
| Mahindra Manulife Small Cap Fund - Direct Plan - Growth | NA | 4065.07 | 5.27 | 4.12 | 14.96 | 3.63 | 0.00 |
| Mahindra Manulife Mid Cap Fund - Direct Plan - Growth | 3 | 3994.38 | 4.43 | 2.73 | 10.28 | 4.17 | 25.60 |
| Mahindra Manulife Large & Mid Cap Fund - Direct Plan - Growth | 1 | 2646.53 | 5.61 | 2.29 | 9.86 | 4.49 | 18.42 |
| Mahindra Manulife Focused Fund - Direct Plan - Growth | 4 | 2127.38 | 5.16 | 4.79 | 8.25 | 7.19 | 21.73 |
| Mahindra Manulife Aggressive Hybrid Fund - Direct Plan - Growth | 5 | 1876.07 | 3.31 | 3.30 | 8.05 | 9.53 | 19.11 |
| Mahindra Manulife Flexi Cap Fund - Direct Plan - Growth | 4 | 1524.48 | 4.39 | 3.77 | 9.08 | 9.18 | 19.43 |
| Mahindra Manulife Business Cycle Fund - Direct Plan - Growth | NA | 1227.72 | 5.76 | 5.19 | 11.19 | 5.69 | 0.00 |
| Mahindra Manulife Liquid Fund - Direct Plan - Growth | 1 | 1012.61 | 0.50 | 1.46 | 3.05 | 6.82 | 7.12 |
| Mahindra Manulife ELSS Tax Saver Fund - Direct Plan - Growth | 3 | 942.34 | 4.36 | 3.57 | 9.01 | 9.04 | 17.21 |